Abstract
Background
SARC-F is recommended as a sarcopenia screening tool and comprised of five assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls.
Objective
The purpose of this study was to assess whether the SARC-F questionnaire in elderly patients with hip fractures was a valid screening tool for sarcopenia by comparison of the results with criteria from the Europe, Asia, and international working groups.
Measurements
115 men and woman with hip fractures were assessed. The SARC-F self-reported questionnaire scores range from 0 to 10 and a score ≥ 4 defines sarcopenia. These survey questions were used to calculate the SARC-F score. Measurements, including appendicular muscle mass, were taken using dual-energy X-ray and grip strength using a dynamometer. Classification using the SARC-F score was compared using the consensus panel criteria from the international, European, and Asian sarcopenia working groups. The performance of all four methods was compared by examining the predictive ability using a ROC curve.
Results
A total of 115 subjects were included and the sarcopenia prevalence rate (SARC-F score ≥ 4) was 63.5 percent. The sensitivity, specificity, positive predictive value, negative predictive value PPV with the EWGSOP-2 criteria in Older People as the reference standard were 95.35 %, 56.94 %, 56.94%, 95.35%, and 71.3%, respectively. In addition, we found similar results for sensitivity and specificity as studies using the EWGSOP and AWGS criteria.
Conclusions
The SARC-F questionnaire is a useful screening tool for elderly patients with hip fractures. This finding supports the recommendation of SARC-F as a screening tool for sarcopenia from the EWGSOP2.
Similar content being viewed by others
Change history
06 August 2020
The original version of this article contained an error in Table and manuscript. The correct information Table and manuscript should be as follows. The authors would like to apologize for any inconvenience caused.
References
Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc 2016;17:675–677.
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al. Epidemiology of Sarcopenia among the Elderly in New Mexico. American Journal of Epidemiology 1998;147:755–763.
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249–256.
Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95–101.
McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res 2015;30:588–592.
Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. Journal of the American Medical Directors Association 2018;19:40–45.e1.
Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630–634.
Choi HJ, Shin CS, Ha Y-C, Jang S, Jang S-M, Jang S et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 2012;30:54–58.
Lee S-R, Ha Y-C, Kang H, Park Y-G, Nam KW, Kim S-R. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci 2013;28:1089–1094.
Hida T, Ishiguro N, Shimokata H, Sakai Y, Matsui Y, Takemura M et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013;13:413–420.
González-Montalvo JI, Alarcón T, Gotor P, Queipo R, Velasco R, Hoyos R et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16:1021–1027.
Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012;55:e48–52.
Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High Prevalence of Sarcopenia in Korean Patients after Hip Fracture: a Case-Control Study. J Korean Med Sci 2016;31:1479–1484.
Morley JE, Cao L. Rapid screening for sarcopenia: Editorial. Journal of Cachexia, Sarcopenia and Muscle 2015;6:312–314.
Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996;3:895–900.
Bahat G, Oren MM, Yilmaz O, Kiliç C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults. J Nutr Health Aging 2018;22:1034–1038.
Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC, Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc 2016;17:1136–1141.
Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Maekawa E et al. Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. J Am Med Dir Assoc 2017;18:176–181.
Acknowledgements
This research was supported by a grant from by the Ministry of SMEs and Startups, Republic of Korea (Project No: P0002726).
Author information
Authors and Affiliations
Contributions
Authors’ contributions: YJI and HYC designed the study. CKJ carried out the data collection. YJI and HYC performed the statistical analysis. WCW and KMJ wrote and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest statement: All authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ha, YC., Won, C.W., Kim, M. et al. SARC-F as a Useful Tool for Screening Sarcopenia in Elderly Patients with Hip Fractures. J Nutr Health Aging 24, 78–82 (2020). https://doi.org/10.1007/s12603-019-1307-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-019-1307-6